The recommendations of the Philadelphia Prostate Cancer Consensus Conference 2019 (held in October last year) on implementation of germline testing for risk of prostate cancer have now been published in the Journal of Clinical Oncology. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk | Tagged: consensus, germline, risk, somatic, testing | 1 Comment »
Last August your sitemaster attended and reported from the third iteration of the Advanced Prostate Cancer Consensus Conference (APCCC), held in Basel, Switzerland (see here, here, and here). … READ MORE …
Filed under: Drugs in development, Living with Prostate Cancer, Management, Treatment | Tagged: advanced, APCCC, conference, consensus | Leave a comment »
Our friends at UroToday are now making available the individual presenters’ slides and other materials from the 3rd Advanced Prostate Cancer Consensus Conference (APCCC) that ended in Basel, Switzerland, last Saturday, as well as detailed interviews on specific topics that were recorded at the meeting. … READ MORE …
Filed under: Uncategorized | Tagged: advanced, APCCC, consensus | Leave a comment »
The first iteration of the Advanced Prostate Cancer Consensus Conference (APCCC) was held in St. Gallen, Switzerland, in 2017, and the second iteration is upcoming in late August this year — this time in Basel. … READ MORE …
Filed under: Management, Treatment | Tagged: advanced, APCCC, consensus, controversy, resolution | 1 Comment »
For those who really want all the details, the full text of the report from the Advanced Prostate Cancer Consensus Conference (APCCC) 2017 is now available on line. … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: advanced, consensus, opinion | 2 Comments »
Apparently, early in 2015, there was a major international consensus conference, among nearly 50 of the leading international authorities, on the treatment of advanced prostate cancer. … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: advanced, conference, consensus, expert, opinion | Leave a comment »
As previously mentioned earlier this week, a long statement that deals with the role of the pathologist in determining the suitability of patients for enrollment into active surveillance management protocols has been issued and endorsed by a number of organizations. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk | Tagged: active, consensus, Diagnosis, Management, pathology, risk, surveillance | 6 Comments »
A paper in the journal Virchows Archiv suggests increasing consensus on both inclusion criteria for management on active surveillance and progression criteria suggesting the need for active treatment. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk | Tagged: active, consensus, pathology, surveillance | 6 Comments »
The Prostate Cancer Roundtable has endorsed a statement developed by the Prostate Health Education Network (PHEN) on the role of PSA testing in the early detection of prostate cancer among men acknowledged to be at elevated risk. … READ MORE …
Filed under: Diagnosis, Risk | Tagged: "high risk", consensus, detection, early, statement | 36 Comments »
THE "NEW" PROSTATE CANCER INFOLINK 